NCT01879137已完成不适用
Copeptin After Arginine Infusion for the Differential Diagnosis of the Polyuria-Polydipsia Syndrome ''The CARGO-Study''
University Hospital, Basel, Switzerland1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2013年6月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Discriminative value of copeptin after arginine infusion in the differential diagnosis of polyuria-polydipsia syndrome.
研究概览
简要总结
the purpose of the study is to investigate whether arginine infusion is a new tool to differentiate patients with diabetes insipidus, primary polydipsia and healthy subjects.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Age over 18 years
- •No medication except hormonal contraception
排除标准
- •Evidence of any acute illness
- •Subjects refusing or unable to give written informed consent
- •Any evidence of disordered drinking habits and diuresis
结局指标
主要结局
Discriminative value of copeptin after arginine infusion in the differential diagnosis of polyuria-polydipsia syndrome.
时间窗: up to 120 minutes after the Arginine infusion.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Use of Copeptin Measurement After Arginine Infusion for the Differential Diagnosis of Diabetes Insipidus - the CARGOx StudyPolydipsia, PrimaryDiabetes InsipidusNCT03572166University Hospital, Basel, Switzerland177
已完成
1 期
Efficacy Study of Oral Arginine to Improve Immune Function in Glioblastoma MultiformeGlioblastoma MultiformeNCT02017249Inova Health Care Services1
已完成
2 期
Arginine Therapy for Sickle Cell Disease PainVaso-occlusive Pain EpisodeSickle Cell DiseaseNCT02536170Emory University108
已完成
4 期
Study of Arginine Free IED in Critically Ill Patients.Critical IllnessNCT01713257Thai Otsuka Pharmaceutical Co., Ltd.172
已完成
4 期
Clinical Study for Assessment of the Efficacy of Gabapentin (Carbatin and Neurontin) in Patients With Neuropathy PainNeuropathyPainNCT02074267Nang Kuang Pharmaceutical Co., Ltd.40